中文(繁體)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Exercise Rehabilitation in Veteran Cancer Survivors

只有註冊用戶可以翻譯文章
登陸註冊
鏈接已保存到剪貼板
狀態招聘中
贊助商
VA Office of Research and Development
合作者
Baltimore VA Medical Center

關鍵詞

抽象

Exercise rehabilitation has the potential as a non-pharmacological approach to reduce persistent neuropathic pain in Veterans with lung cancer. By examining the effects of exercise training in Veteran cancer survivors with NSCLC, there is the potential to revolutionize care for a: common, debilitating, and inadequately treated symptom in a growing population. This could lead to a larger investigation to fill critical gaps in the literature and at the same time help discover a new model of care for Veterans with chronic pain. The ultimate goal is to reduce this type of pain for the growing population of cancer survivors while simultaneously reducing the need for problematic opioid management.

描述

Persistent or chronic neuropathic pain, either post-thoracotomy persistent pain (PTPP) or chemotherapy-induced peripheral neuropathy (CIPN) occurs in a majority of lung cancer patients. Thus, not only is this neuropathic pain widespread; there is no way to prevent its development, and long-term use of opioids for control of symptoms could result in addiction. Ultimately, PTPP and CIPN can lead to long-term suffering and disability during the post-treatment phase.(NSCLC), which represents about 85% of lung cancer cases.This is the first project of its kind and the potential impact of this research is large, because exercise training will be a prescription and the first approach for which NSCLC survivors can self-manage chronic neuropathic pain. The ultimate goal of the investigators' work is to reduce neuropathic pain for the growing population of cancer survivors while simultaneously reducing the need for problematic pharmacologic management. Therefore, results of this study have potential for high impact on symptom care because it will allow effective neuropathic pain treatment to be in full control of the Veteran, and likely restore function that is lost during the chronic pain experience.

Specific Aims:

1. To determine the feasibility of conducting an exercise rehabilitation intervention in Veterans with NSCLC and PTPP or CIPN.

2. To determine the effects of a VAMHCS-supervised activity rehabilitation program on chronic pain, and sensory thresholds (thermal, static, and dynamic) compared to delayed control.

3. To assess changes in fitness, strength, physical function, fatigue, and quality of life (QoL) after activity-based rehabilitation compared to control period.

日期

最後驗證: 06/30/2020
首次提交: 08/02/2018
提交的預估入學人數: 08/02/2018
首次發布: 08/07/2018
上次提交的更新: 07/14/2020
最近更新發布: 07/15/2020
實際學習開始日期: 08/18/2019
預計主要完成日期: 12/29/2021
預計完成日期: 12/29/2022

狀況或疾病

Cancer

干預/治療

Behavioral: Exercise Rehabilitation

Other: Control

-

手臂組

干預/治療
Other: Control
Participants maintain their current activity level.
Other: Control
Participants are instructed to maintain current activity level and are monitored for changes.
Active Comparator: Exercise Rehabilitation
Participants will exercise 2x/week at training facilities and at home one day a week.
Behavioral: Exercise Rehabilitation
This training is designed to improve fitness, target the major muscle groups for strength, and to improve balance. Aerobic exercise of walking on a treadmill will be performed. Thera-Bands will be used for resistance exercise for the lower and upper body. Balance program includes core exercises (stepping, weight shifts, etc.) and other progressive exercises.

資格標準

有資格學習的年齡 60 Years 至 60 Years
有資格學習的性別All
接受健康志願者
標準

Inclusion Criteria:

1. Age 60-80 years

2. Diagnosis with lung cancer

3. History of treatment with either thoracotomy procedure or neurotoxic chemotherapy or both

4. Completion of thoracotomy or chemotherapy > or = 6 months

5. Ability to walk on a treadmill

6. Karnofsky performance status > 70

7. Score > 1 Neuropathic Pain Scale

Exclusion Criteria:

1. Presence of metastatic (stage IV)

2. Life expectancy < 6 months

3. Musculoskeletal or medical conditions which preclude participation in an exercise program

結果

主要結果指標

1. Pain Visual Analog Scale Change [Measured at baseline, after 6 weeks control, and after 6 week intervention]

Scale of 0 (no pain) to 100 (worst imaginable pain)

次要成果指標

1. Patient-Reported Outcomes Measurement System Neuropathic Pain Quality (PROMIS-PQ Neuro) Change [Measured at baseline, after 6 weeks control, and after 6 week intervention]

0-10 numeric rating

2. Fitness Change [Measured at baseline, after 6 weeks control, and after 6 week intervention]

VO2peak

3. Strength Change [Measured at baseline, after 6 weeks control, and after 6 week intervention]

knee extensor strength

4. Pain change [Measured at baseline, after 6 weeks control, and after 6 week intervention]

Sensory thresholds

加入我們的臉書專頁

科學支持的最完整的草藥數據庫

  • 支持55種語言
  • 科學支持的草藥療法
  • 通過圖像識別草藥
  • 交互式GPS地圖-在位置標記草藥(即將推出)
  • 閱讀與您的搜索相關的科學出版物
  • 通過藥效搜索藥草
  • 組織您的興趣並及時了解新聞研究,臨床試驗和專利

輸入症狀或疾病,並閱讀可能有用的草藥,輸入草藥並查看其所針對的疾病和症狀。
*所有信息均基於已發表的科學研究

Google Play badgeApp Store badge